Alzinova initiates development of a stable cell line to prepare the monoclonal antibody ALZ-201 for Alzheimer's clinical trials
/PRNewswire/ -- Alzinova AB (publ) ("Alzinova" or the "Company") today announces the initiation of the next step in the preclinical development of its...